Cargando…
Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2
Cross-reactive immunity between SARS-CoV-2 and other related coronaviruses has been well-documented, and it may play a role in preventing severe COVID-19. Epidemiological studies early in the pandemic showed a geographical association between high influenza vaccination rates and lower incidence of S...
Autores principales: | Chaisawangwong, Worarat, Wang, Hanzhi, Kouo, Theodore, Salathe, Sebastian F., Isser, Ariel, Bieler, Joan Glick, Zhang, Maya L., Livingston, Natalie K., Li, Shuyi, Horowitz, Joseph J., Samet, Ron E., Zyskind, Israel, Rosenberg, Avi Z., Schneck, Jonathan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675569/ https://www.ncbi.nlm.nih.gov/pubmed/36134660 http://dx.doi.org/10.1172/jci.insight.158308 |
Ejemplares similares
-
SARS-CoV-2 Infection in Winter 2021/2022: The Association of Varying Clinical Manifestations With and Without Prior Vaccination
por: Jacobs, Menachem, et al.
Publicado: (2022) -
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022) -
Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021) -
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021) -
SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)